Active ingredient
Glucose
88 finished FDA listings contain Glucose as their only active ingredient; 230 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- ANHYDROUS DEXTROSE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, UNSPECIFIED FORM
- Dosage forms
- Injection, Injection, Solution, Injection, Solution, Concentrate, Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 19
- Strengths listed
- 10 g/100ml · 100 g/1000ml · 100 mg/ml · 12500 mg/250ml · 2.5 g/50ml · 20 g/100ml · 25 g/50ml · 250 mg/ml · 2500 mg/50ml · 25000 mg/500ml · 3.21 g/63ml · 3.57 g/70ml · 30 g/100ml · 4.64 g/100ml · 40 g/100ml · 5 g/100ml · 50 g/1000ml · 50 g/100ml · 50 mg/ml · 5000 mg/100ml · 70 g/100ml
- Brand names in FDA listings
- Blood Collection System, Dextrose, Infant Dextrose, Leukotrap Rc Pl System, Leukotrap Rc System, Leukotrap Wb System - Cp2d
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 4850
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 016694 | BAXTER HLTHCARE | 1971-01-25 | 1 |
| NDA 016367 | OTSUKA ICU MEDCL | 1971-02-12 | 2 |
| NDA 016673 | BAXTER HLTHCARE | 1971-03-04 | 11 |
| NDA 016730 | B BRAUN | 1973-12-21 | 1 |
| NDA 018080 | OTSUKA ICU MEDCL | 1979-08-28 | 2 |
| NDA 018561 | OTSUKA ICU MEDCL | 1982-03-23 | 1 |
| NDA 018564 | OTSUKA ICU MEDCL | 1982-03-23 | 1 |
| NDA 018562 | OTSUKA ICU MEDCL | 1982-03-23 | 1 |
| NDA 018563 | OTSUKA ICU MEDCL | 1982-03-23 | 1 |
| NDA 019345 | OTSUKA ICU MEDCL | 1985-01-26 | 1 |
| NDA 019466 | HOSPIRA | 1985-07-15 | 1 |
| NDA 019445 | HOSPIRA | 1986-06-03 | 15 |
| NDA 019626 | B BRAUN | 1988-02-02 | 3 |
| NDA 019893 | OTSUKA ICU MEDCL | 1989-12-26 | 1 |
| NDA 020047 | BAXTER HLTHCARE | 1991-07-02 | 1 |
| NDA 020179 | BAXTER HLTHCARE | 1992-12-07 | 13 |
| ANDA 207449 | FRESENIUS KABI USA | 2016-10-21 | 13 |
| ANDA 209448 | FRESENIUS KABI USA | 2018-07-16 | 3 |
| ANDA 203451 | INTL MEDICATION SYS | 2021-03-26 | 3 |
Official labeling on DailyMed
- DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HENRY SCHEIN, INC.] · version 7 · 2026-09-11
- DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [REMEDYREPACK INC.] · version 5 · 2026-09-02
- LEUKOTRAP WB SYSTEM - CP2D (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 1 · 2026-08-17
- LEUKOTRAP RC PL SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 1 · 2026-08-17
- LEUKOTRAP RC SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 1 · 2026-08-07
- LEUKOTRAP RC SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 1 · 2026-08-07
- LEUKOTRAP RC PL SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 1 · 2026-08-07
- LEUKOTRAP RC SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 3 · 2026-08-07
- LEUKOTRAP WB SYSTEM - CP2D (CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 2 · 2026-08-07
- LEUKOTRAP WB SYSTEM - CP2D (CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 2 · 2026-08-07
- LEUKOTRAP RC PL SYSTEM (CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM) SOLUTION [GVS TM INC] · version 2 · 2026-08-07
- DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] · version 34 · 2026-07-15
Showing the 12 most recent of 54 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.